Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from DHR

What to Expect From Danaher's Next Quarterly Earnings Report

Danaher is expected to release its second-quarter earnings later this month, and analysts project a double-digit bottom-line dip.

Barchart

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is poised for tremendous growth driven by the aging population and rising incidence of chronic diseases. Hence, quality healthcare stocks, Danaher (DHR), Amgen (AMGN), and DexCom (DXCM), benefiting from an aging population, might be worth looking into. Read more….

StockNews.com

Impactful and meaningful research will solve problems of Indian citizens, says ICMR Director-General

Indian medical institutions aim to improve research quality and global rankings, focusing on impactful solutions for citizens' problems.

The Hindu

From analysis to the latest developments in health,
read the most diverse news in one place.

Veralto: The Unassuming ESG Powerhouse That Will Likely Double

In the specialized field of spinoff companies, Veralto emerges as a prime investment opportunity, stemming from its recent spinoff from Danaher Corporation.

Barchart

Danaher (DHR) vs. Stryker (SYK) - Analyzing Anticipated Q4 Earnings

With rapidly increasing healthcare demands, numerous technological breakthroughs, and advanced research and development, the medical industry is well-poised for remarkable growth and profitability. As medical companies Danaher (DHR) and Stryker (SYK) gear to report their fourth-quarter earnings tomorrow, let’s determine if these stocks are ideal buys ahead of earnings….

StockNews.com

Danaher Corp Has Unusual Stock Options Activity - Highlighting Value in DHR Stock

Danaher Corp, the biotech/life sciences products firm, has had unusual call options activity today. It highlights the value of shorting out-of-the-money "covered calls" in DHR stock as an income play.

Barchart

Buy Veralto The Spinoff from Danaher Is A Good Bet

Spinoffs and Parents in these sectors do well. 23 years of data from says that Large-cap Parents and Spinoffs within the Healthcare and Industrials sector observe a consistent trend of outperformance. This suggests that investors could see a similar trend with DHR and VLTO post-Spin.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Are These 3 Medical Stocks Worth Buying?

The increased demand for healthcare services and technological advancements are poised to keep the healthcare industry buoyed in the foreseeable future. Given this backdrop, are medical stocks Danaher Corporation (DHR), IQVIA Holdings (IQV), and Bio-Rad Laboratories (BIO) worth buying now? Read on to find more….

StockNews.com

3 of the Strongest Stocks to Buy Right Now

Rekindled recession worries amid upheaval in the banking sector and the Fed’s further tightening of monetary policy could keep the stock market volatile in the near term. Given this backdrop, we think the strong growth prospects of UnitedHealth Group (UNH), Danaher Corp. (DHR), and ServiceNow (NOW) make these stocks solid…

StockNews.com

Met Police ‘missed chances to protect woman killed by ex-husband with crossbow’

Two officers binned a ‘burglary kit’ linked to the killer, discovered outside his ex-wife’s home the year before she was murdered.

The Independent UK

2 Stocks to Buy Now at Knocked-Down Prices

With steady growth in employment during November, slower but surer interest rate hikes by the Fed to fight inflation threaten to keep markets subdued and the economy sluggish next year. Therefore, it could be wise to load up on shares of businesses with robust demand and a stable growth trajectory,…

StockNews.com

2 Deeply Discounted Stocks to Buy Now

The Fed’s aggressive monetary policy stance and high inflation levels have led to a broad stock market sell-off this year. Analysts continue to expect a recession with minimal chances of a soft landing. As value investing gains traction, fundamentally sound stocks Microsoft (MSFT) and Danaher (DHR), which are trading at…

StockNews.com

Check Out What Whales Are Doing With DHR

Someone with a lot of money to spend has taken a bullish stance on Danaher (NYSE:DHR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Danaher Whale Trades For October 04

A whale with a lot of money to spend has taken a noticeably bearish stance on Danaher. Looking at options history for Danaher (NYSE:DHR) we detected 10 strange trades.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Reason

Father's Tort Claim Based on Alleged Falsification of Drug Test Results Can Go Forward

From Avendano v. Shaw, decided Friday by a five-Justice division of the Alabama Supreme Court (in an opinion by Justice James Mitchell, joined by Chief Justice Tom Parker; Justices Greg Shaw, Tommy Bryan, and Brady Mendheim concurred in the result, but without a separate opinion): This case stems from the…

Benzinga

Here's How Much $100 Invested In Danaher 20 Years Ago Would Be Worth Today

Danaher (NYSE:DHR) has outperformed the market over the past 20 years by 7.67% on an annualized basis producing an average annual return of 14.78%. Currently, Danaher has a market capitalization of $186.88 billion.

Benzinga

$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today

Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 9.25% on an annualized basis producing an average annual return of 20.62%. Currently, Danaher has a market capitalization of $184.66 billion.

Benzinga

Here's How Much $100 Invested In Danaher 10 Years Ago Would Be Worth Today

Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 8.15% on an annualized basis producing an average annual return of 19.71%. Currently, Danaher has a market capitalization of $180.36 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Danaher Clocks Q1 Sales Jump Of 12%, COVID-19-Related Restrictions In China To Impact Q2 Sales

Danaher Corp (NYSE:DHR) logged Q1 FY22 adjusted EPS of $2.76, up 9.5% Y/Y, surpassing the estimate of $2.66. Sales increased 12% to $7.7 billion, with 12% non-GAAP core and 8.0% non-GAAP base business core revenue growth, beating the $7.54 billion estimate. Operating cash flow reached $2 billion. Non-GAAP free cash flow reached…

Benzinga

Danaher: Q1 Earnings Insights

Danaher (NYSE:DHR) reported its Q1 earnings results on Thursday, April 21, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

StockNews.com

4 Beaten-Down Dividend Growth Stocks to Scoop Up Now

The major benchmark indices posted their best day since mid-March on Tuesday. However, with the International Monetary Fund (IMF) reducing its global economic growth forecast, citing the Russia-Ukraine war and rising inflation as key contributors, the market could remain volatile in the near term. Thus, we think beaten-down dividend stocks…

Benzinga

Here's How Much $1000 Invested In Danaher 15 Years Ago Would Be Worth Today

Danaher (NYSE:DHR) has outperformed the market over the past 15 years by 7.05% on an annualized basis producing an average annual return of 14.59%. Currently, Danaher has a market capitalization of $195.51 billion.

StockNews.com

5 Top Mega-Cap Stocks in the Healthcare Sector to Buy This Month

The healthcare sector is known for its defensive qualities. Therefore, betting on mega-cap healthcare stocks could be one of the best ways to generate stable returns amid the current, extended, market volatility. We think their solid growth attributes and profit margins make the stocks of Novartis (NVS), Danaher (DHR), Eli…

Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 15 Years

Danaher (NYSE:DHR) has outperformed the market over the past 15 years by 7.23% on an annualized basis producing an average annual return of 15.22%. Currently, Danaher has a market capitalization of $212.45 billion.

Benzinga

Looking At Danaher's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Danaher (NYSE:DHR). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 2 3

People

Mangeet Kaur BounsMangeet

595 stories

Steve Reitmeister

508 stories

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Verizon Communications Inc

114 stories

NVS

89 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.